Search
Revaprazan
go.drugbank.com/drugs/DB16308InvestigationalRevaprazan is under investigation in clinical trial NCT01750437 (Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(nerd)).
Synonyms: Yh-1885 free baseInsulin human
go.drugbank.com/drugs/DB00030ApprovedInvestigationalHuman insulin is also available in an intermediate-acting form as NPH (Neutral Protamine Hagedorn) as the marketed products Novolin N and Humulin N. … Marketed as the brand name product Humulin R or Novolin R, human insulin begins to exert its effects within 30 minutes of subcutaneous administration, while peak levels occur 3-4 hours after administration
Mixtures: Novolin Ge 30/70, Novolin Ge 30/70Products: HUMINSULIN BAS NPH KWIKPEN, Novolin NArimoclomol
go.drugbank.com/drugs/DB05025Approved[L51384] Arimoclomol was approved by the FDA on September 20, 2024, making it the first treatment for Niemann-Pick disease, type C (NPC).
Synonyms: BRX-220 FREE BASEJTC-801 free base
go.drugbank.com/drugs/DB17033ExperimentalAn antagonist of nociceptin receptor and analgesic agent, evaluated for its use in cancer treatment.
Synonyms: JTC-801 free baseSKF-96365 free base
go.drugbank.com/drugs/DB17054ExperimentalSKF-96365 is a receptor-mediated calcium entry (RMCE) inhibitor structurally different from other calcium antagonists.
Synonyms: SKF-96365 free baseSEL120-34A free base
go.drugbank.com/drugs/DB18107InvestigationalSynonyms: Cdk8-in-2 free base, SEL120-34A free base